U-Blot® Research Grade Anti-Human ERBB3/HER3 (GSK2849330)Cat. No. WA1900$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human ERBB3/HER3 (GSK2849330)Cat. No. WA1900
U-Blot® Research Grade Anti-Human ERBB3/HER3 (CDX-3379)Cat. No. WA1899
U-Blot® Research Grade Anti-Human ERBB3/HER3 (AV-203)Cat. No. WA1898
U-Blot® Research Grade Anti-Human ERBB3/HER3 (29Z6)Cat. No. WA1897
U-Blot® Research Grade Anti-Human EPOR (rhEPO-Fc)Cat. No. WA1896
U-Blot® Research Grade Anti-Human EPHA4 Antibody (MEDI-542)Cat. No. WA1895
U-Blot® Research Grade Anti-Human EPHA4 (PF-06647263)Cat. No. WA1894
U-Blot® Research Grade Anti-Human EPHA2 (MEDI-547)Cat. No. WA1893
U-Blot® Research Grade Anti-Human EPHA2 (DS-8895a)Cat. No. WA1892
U-Blot® Research Grade Anti-Human ENO1/Alpha-enolase (HuL001)Cat. No. WA1891
U-Blot® Research Grade Anti-Human EMP2 (PG-101)Cat. No. WA1890
U-Blot® Research Grade Anti-Human EGFR/ERBB1/HER1 Antibody (Duke D2C7)Cat. No. WA1889